Synthetic copolymer kit for radionuclide blood-pool imaging

Area of Science:

• Nuclear medicine
• Radiopharmaceutical chemistry
• Polymer science

Background:

• Blood pool imaging is crucial for diagnosing various cardiovascular and hematological conditions.
• Current methods, such as radiolabeled red blood cells (RBCs), have limitations in stability and preparation.
• Development of novel, stable, and effective blood pool imaging agents is essential for improving diagnostic accuracy.

Purpose of the Study:

• To synthesize and characterize a novel synthetic blood pool imaging agent labeled with technetium-99m (99mTc).
• To evaluate the stability, biodistribution, and imaging properties of the 99mTc-labeled agent in preclinical models.
• To compare the efficacy of the novel agent with 99mTc-labeled RBCs for blood pool imaging.

Main Methods:

• Synthesis of methoxypolyethylene glycol-poly-L-lysyl-diethylenetriaminepentaacetate monoamide and its subsequent radiolabeling with 99mTc.
• Assessment of radiochemical purity and stability using HPLC.
• Biodistribution studies in rats and blood pool imaging/clearance studies in rabbits and a rhesus monkey.
• Comparison of imaging performance with 99mTc-labeled RBCs in a rhesus monkey.

Main Results:

• The 99mTc-labeled agent demonstrated high radiochemical purity (>98%) and excellent stability in solution.
• Prolonged blood circulation with a half-life of 31.5 hours in rabbits and minimal accumulation in the reticuloendothelial system.
• Similar heart-to-lung ratios were observed compared to 99mTc-RBCs, remaining stable for up to 15 hours postinjection.

Conclusions:

• The 99mTc-labeled synthetic polymer is a highly stable and effective agent for blood pool imaging.
• It presents a promising alternative to traditional 99mTc-labeled RBCs, offering improved stability and comparable imaging characteristics.
• This novel agent has the potential to enhance diagnostic applications in nuclear medicine.